Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

5 May 2021 10:22

RNS Number : 6258X
Hongkong Land Hldgs Ltd
05 May 2021
Β 

Announcement

Β 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

Β 

HONGKONGΒ LANDΒ HOLDINGSΒ LIMITED

InterimΒ ManagementΒ Statement

Β 

5thΒ May 2021 - Hongkong Land Holdings Limited today issues an Interim Management Statement for the first quarter of 2021.

Β 

The Group continues to operate in a challenging environment and uncertainty remains about the duration of COVID-19 and the impact it will have on the Group's full-year underlying performance. The Group's balance sheet remains strong and well-financed.

Β 

The Group's Investment Properties portfolio continued to demonstrate resilience in the period, underpinned by its high-quality tenant base and active lease management, whilst the Development Properties business benefited from improving market conditions on the Chinese mainland and in Singapore.

Β 

In Hong Kong, rental reversions in the Group's Hong Kong Central office portfolio were negative, reflecting the general decrease in rents since the onset of the pandemic. Physical vacancy at 31st March 2021 was 7.6%, compared to 6.3% at the end of 2020. On a committed basis, vacancy was 6.8%, compared to 5.9% at the end of 2020. However, new office leasing activity saw a modest increase in the period as a result of improved sentiment and a narrowing rental gap between Central and other parts of the city.

Β 

The Group's Central retail portfolio benefited from marginally better trading conditions in the quarter compared to the prior year, although luxury retail sentiment remains weak relative to pre-pandemic levels. Base rental reversions were negative, reflecting lower retail rents across Hong Kong. The Group continued to provide temporary rent relief to support its tenants on a case-by-case basis. Physical vacancy at 31st March 2021 was 1.7% compared to 0.3% at the end of 2020. On a committed basis, vacancy was 0.4%, compared to 0.3% at the end of 2020.

Β 

Rental reversions in the Group's Singapore office portfolio were mildly negative in the period, although they are expected to turn positive before the end of June as tenants take up committed space. Physical vacancy increased to 7.9% at 31st March 2021 from 2.1% at the end of 2020 due to the timing of new tenant occupancy. On a committed basis, however, vacancy remained low at 3.0%, compared to 2.1% at the end of 2020.

Β 

In Beijing, the trading performance at WF CENTRAL continued to benefit from the strength of luxury retail sentiment on the Chinese mainland, with first quarter tenant sales exceeding those achieved in the equivalent period in 2020.

Β 

In Shanghai, construction has commenced at the Group's prime mixed-use joint development on the West Bund, with completion in multiple phases to 2027.

Β 

In Development Properties, the Group's attributable interest in contracted sales on the Chinese mainland was US$410 million in the first quarter, compared to US$107 million in the equivalent period in 2020, due to the effect of pandemic-related suspensions of sales and development activities in the prior year. In Singapore, the Group's attributable interest in contracted sales was US$89 million in the quarter, compared to US$170 million in the equivalent period in 2020, due to the timing of sales launches, although buyer sentiment improved.

Β 

Hongkong Land participated in a number of land auctions on the Chinese mainland during the first quarter, but it remained difficult to secure new sites due to a highly competitive primary land market.

Β 

In the rest of Southeast Asia, construction activities at the Group's Development Properties projects remain partially curtailed by the pandemic and market sentiment remains subdued.

Β 

The Group's financial position remains strong. Net debt at 31st March 2021 was US$4.2 billion, compared to US$4.6 billion at the end of 2020. Committed liquidity was US$4.3 billion, unchanged from the end of 2020.

Β 

Hongkong Land is a major listed property investment, management and development group. The Group owns and manages more than 850,000 sq. m. of prime office and luxury retail property in key Asian cities, principally in Hong Kong, Singapore, Beijing and Jakarta. The Group also has a number of high quality residential, commercial and mixed-use projects under development in cities across China and Southeast Asia. In Singapore, its subsidiary, MCL Land, is a well-established residential developer. Hongkong Land Holdings Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. The Group's assets and investments are managed from Hong Kong by Hongkong Land Limited. Hongkong Land is a member of the Jardine Matheson Group.

Β 

-Β endΒ -

Β 

ForΒ furtherΒ information,Β pleaseΒ contact:

Β 

Hongkong Land Limited

Robert Wong

(852) 2842 8428

Simon Dixon

(852) 2842 8101

Mark Lam

(852) 2842 8211

Β 

BrunswickΒ GroupΒ Limited

Andrea Ngai

(852) 3512 5093

Β 

This and other Group announcements can be accessed through the Internet atΒ 'www.hkland.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DOCZZGGKLKGGMZG
Date   Source Headline
8th May 201912:32 pmRNSInterim Management Statement
2nd May 201910:20 amRNSDividend
29th Apr 201910:49 amRNSFirst Quarter 2019 Results of PT Hero
26th Apr 201910:35 amRNSJC&C 2019 First Quarter Financial Statements
24th Apr 201911:09 amRNSPT Astra 2019 First Quarter Financial Statements
18th Apr 201910:57 amRNSDividend
4th Apr 201910:11 amRNSAnnual Financial Report
29th Mar 20199:15 amRNSTotal Voting Rights
27th Mar 20199:12 amRNSCirc re. Scrip Dividend Scheme
26th Mar 20199:14 amRNSDirector/PDMR Shareholding
25th Mar 20199:12 amRNSBlock listing Interim Review
20th Mar 201910:53 amRNSDirector/PDMR Shareholding
7th Mar 20199:12 amRNSDirector/PDMR Shareholding
28th Feb 20199:25 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:23 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:19 amRNSFull Year 2018 Results of PT Hero
28th Feb 20199:18 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 Preliminary Announcement of Results
27th Feb 20199:50 amRNSJC&C 2018 Financial Statements
27th Feb 20199:41 amRNSPT Astra Intl TBK - 2018 FY Financial Statements
31st Jan 20199:07 amRNSTotal Voting Rights
30th Jan 20199:15 amRNSNotice of 2018 Final Results
24th Jan 201911:08 amRNSDirector/PDMR Shareholding
8th Jan 201910:18 amRNSDirector/PDMR Shareholding
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 201811:32 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
7th Dec 20189:08 amRNSDirectorate Change
30th Nov 20189:16 amRNSTotal Voting Rights
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:10 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
24th Oct 201811:31 amRNSDirector/PDMR Shareholding
11th Oct 201811:52 amRNSDirector/PDMR Shareholding
10th Oct 201810:13 amRNSDirector/PDMR Shareholding
5th Oct 201810:35 amRNSAdditional Listing
2nd Oct 201811:04 amRNSForm 8.3 - Jardine Lloyd Thompson Group plc
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.